Clinical Pharmacokinetics

Bioequivalence Criteria for Transdermal Fentanyl Generics: Do These Need a Relook?
pp. 625-633(9)
Authors: Walter, Carmen; Felden, Lisa; Lötsch, Jörn

Pharmacology of Morphine in Obese Patients: Clinical Implications
pp. 635-651(17)
Authors: >Célia Lloret Linares,; Declèves, Xavier; >Jean Michel Oppert,; Basdevant, Arnaud; Clement, Karine; Bardin, Christophe; >Jean Michel Scherrmann,; >Jean Pierre Lepine,; Bergmann, Jean François; Mouly, Stéphane

A Proposal for a Pharmacokinetic Interaction Significance Classification System (PISCS) Based on Predicted Drug Exposure Changes and Its Potential Application to Alert Classifications in Product Labelling
pp. 653-666(14)
Authors: Hisaka, Akihiro; Kusama, Makiko; Ohno, Yoshiyuki; Sugiyama, Yuichi; Suzuki, Hiroshi

Pharmacokinetic Modelling and Development of Bayesian Estimators for Therapeutic Drug Monitoring of Mycophenolate Mofetil in Reduced-Intensity Haematopoietic Stem Cell Transplantation
pp. 667-675(9)
Authors: Saint-Marcoux, Franck; Royer, Bernard; Debord, Jean; Larosa, Fabrice; Legrand, Faezeh; Deconinck, Eric; Kantelip, Jean-Pierre; Marquet, Pierre

Effect of Cytochrome P450 2D6 Genotype on Maternal Paroxetine Plasma Concentrations during Pregnancy
pp. 677-683(7)
Authors: Ververs, F.F. Tessa; Voorbij, Heronimus A.M.; Zwarts, Petra; Belitser, Svetlana V.; Egberts, Toine C.G.; Visser, Gerard H.A.; Schobben, Alfred F.A.M.

Population Pharmacokinetics and Dosing Recommendations for Cisplatin during Intraperitoneal Peroperative Administration
pp. 685-686(2)
Author: Ehrsson, Hans

The Authors' Reply
pp. 686-687(2)
Author: Royer, Bernard